Andlauer Healthcare Group Past Earnings Performance
Past criteria checks 2/6
Andlauer Healthcare Group has been growing earnings at an average annual rate of 24.6%, while the Healthcare industry saw earnings growing at 0.3% annually. Revenues have been growing at an average rate of 22.5% per year. Andlauer Healthcare Group's return on equity is 14.1%, and it has net margins of 10.2%.
Key information
24.6%
Earnings growth rate
21.4%
EPS growth rate
| Healthcare Industry Growth | -6.7% |
| Revenue growth rate | 22.5% |
| Return on equity | 14.1% |
| Net Margin | 10.2% |
| Next Earnings Update | 02 May 2024 |
Recent past performance updates
Recent updates
These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Reasonably Well
Jan 30
Return Trends At Andlauer Healthcare Group (TSE:AND) Aren't Appealing
Aug 24Market Participants Recognise Andlauer Healthcare Group Inc.'s (TSE:AND) Earnings
May 05Is Andlauer Healthcare Group (TSE:AND) Using Too Much Debt?
Apr 07A Look At The Fair Value Of Andlauer Healthcare Group Inc. (TSE:AND)
Dec 22Andlauer Healthcare Group (TSE:AND) Hasn't Managed To Accelerate Its Returns
Dec 09We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease
Oct 28These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Safely
Oct 12Here's What To Make Of Andlauer Healthcare Group's (TSE:AND) Decelerating Rates Of Return
Aug 17We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease
Jul 19Andlauer Healthcare Group (TSE:AND) Could Easily Take On More Debt
Jul 05The Returns At Andlauer Healthcare Group (TSE:AND) Aren't Growing
May 04I Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease
Apr 19Is Andlauer Healthcare Group (TSE:AND) A Risky Investment?
Feb 23Is There An Opportunity With Andlauer Healthcare Group Inc.'s (TSE:AND) 33% Undervaluation?
Jan 19We Think Andlauer Healthcare Group (TSE:AND) Might Have The DNA Of A Multi-Bagger
Jan 06Should You Be Adding Andlauer Healthcare Group (TSE:AND) To Your Watchlist Today?
Dec 15Is Andlauer Healthcare Group (TSE:AND) A Risky Investment?
Nov 17Returns On Capital Are Showing Encouraging Signs At Andlauer Healthcare Group (TSE:AND)
Sep 20Is There An Opportunity With Andlauer Healthcare Group Inc.'s (TSE:AND) 44% Undervaluation?
Sep 03Do Andlauer Healthcare Group's (TSE:AND) Earnings Warrant Your Attention?
Aug 12Is Andlauer Healthcare Group (TSE:AND) A Risky Investment?
May 29Why We Like The Returns At Andlauer Healthcare Group (TSE:AND)
May 03Revenue & Expenses BreakdownBeta
How Andlauer Healthcare Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 648 | 66 | 51 | 0 |
| 30 Sep 23 | 645 | 67 | 52 | 0 |
| 30 Jun 23 | 653 | 71 | 51 | 0 |
| 31 Mar 23 | 665 | 76 | 50 | 0 |
| 31 Dec 22 | 648 | 76 | 48 | 0 |
| 30 Sep 22 | 616 | 110 | 44 | 0 |
| 30 Jun 22 | 555 | 103 | 41 | 0 |
| 31 Mar 22 | 493 | 95 | 38 | 0 |
| 31 Dec 21 | 440 | 90 | 35 | 0 |
| 30 Sep 21 | 394 | 51 | 32 | 0 |
| 30 Jun 21 | 365 | 47 | 31 | 0 |
| 31 Mar 21 | 328 | 41 | 29 | 0 |
| 31 Dec 20 | 314 | 38 | 29 | 0 |
| 30 Sep 20 | 304 | 31 | 29 | 0 |
| 30 Jun 20 | 299 | 30 | 27 | 0 |
| 31 Mar 20 | 300 | 31 | 26 | 0 |
| 31 Dec 19 | 290 | 30 | 23 | 0 |
| 30 Sep 19 | 285 | 28 | 20 | 0 |
| 31 Dec 18 | 277 | 27 | 22 | 0 |
| 31 Dec 17 | 251 | 22 | 20 | 0 |
| 31 Dec 16 | 224 | 19 | 21 | 0 |
Quality Earnings: AND has high quality earnings.
Growing Profit Margin: AND's current net profit margins (10.2%) are lower than last year (11.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AND's earnings have grown significantly by 24.6% per year over the past 5 years.
Accelerating Growth: AND's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: AND had negative earnings growth (-13.3%) over the past year, making it difficult to compare to the Healthcare industry average (6.3%).
Return on Equity
High ROE: AND's Return on Equity (14.1%) is considered low.